SCHEMBL13006229

SCHEMBL13006229

Nc1ccc2c(c1[N+](=O)[O-])CCCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
USP2 O75604 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
ACHE P22303 3/20 0.38
TDP1 Q9NUW8 5/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP3A4 P08684 3/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2245003 0.98 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2245425 0.95 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29119413 0.80 HTR2C (0.55) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL11332933 0.80 PNMT (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29119458 0.79 HTR2A (0.56) MEN1KMT2AUSP2KEAP1NFE2L2
SCHEMBL9452596 0.79 HTR2A (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29720579 0.79 HTR2A (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL19830023 0.79 ALDH1A1 (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL9671688 0.77 GRIN2D (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6996430 0.77 BCL2L1 (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866292-B1 TRICYCLIC 1,2,4-TRIAZINE OXIDES AND COMPOSITIONS THEREFROM FOR THERAPEUTIC USE IN CANCER TREATMENTS AUCKLAND UNISERVICES LTD (NZ) 2010-12-15 EP disclosed